ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryGenevaMPC Therapeutics SA
MPC Therapeutics SA Logo
Verified· 3 sources

MPC Therapeutics SA

Summary

About the company

The core activity of MPC Therapeutics SA is the development of innovative products that improve the fitness, persistence and performance of cells, particularly T cells, mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs). This is achieved through modulation of mitochondrial function, specifically by targeted influence on the mitochondrial pyruvate carrier (MPC) and other key metabolic pathways. The company develops small molecules that modulate mitochondrial function to enhance the therapeutic efficacy of cell therapies.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered3
MitoRange products
Metabolic enhancers for cell therapies, including MitoStem™, MitoGrow™ and MitoFit™; reagents for T-cell fitness, CAR-T expansion and metabolic modulation.
Metabolic modulation for cell therapies
Small-molecule metabolic modulation solutions to improve quality, durability and persistence of cell therapies, with applications for immune cells, stem cells and biomanufacturing.
Partnerships for the translation of cell therapy technologies
Collaborations with cell therapy developers and biomanufacturing leaders to translate metabolic modulation into scalable solutions for preclinical, RUO and GMP contexts.
Press

Media

January 10, 2023Media
CHF 1.5M for MPC Therapeutics Expanding Pipeline
startupticker.ch
Comparisons

MPC Therapeutics SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank MPC Therapeutics SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of MPC Therapeutics SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Route de Florissant 53
1206 Geneva

At a glance

Legal form
Corporation
UID
CHE-432.161.098
Founded
2018 · 8 years
Last commercial register change
August 28, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once MPC Therapeutics SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

AS
Ageronix SA
Carouge Ge
KB
KBI Biopharma SA
Plan-Les-Ouates
OP
OM Pharma SA
Meyrin
MM
MMV MEDICINES FOR MALARIA VENTURE
Cointrin
IT
IREMIS Therapeutics SA
Anières
SG
SANOFI GESTION SA
Vernier
IS
Impingo Sàrl
Meyrin
LP
Labatec Pharma SA
Meyrin